Greece – Fertility destination 2021
Choosing an IVF clinic can be a daunting task; there are many treatment providers in different countries offering diverse solutions to fertility issues and it is no wonder that patients seeking answers don’t really know where to start.
IFC is very pleased to act as an Ambassador for the Fertility Destination campaign which will enable anyone considering fertility travel an opportunity to learn about the very best clinics and professionals that individual countries have to offer.
The campaign launches with Greece – Fertility Destination 2021 which will showcase treatment opportunities; clinic facilities, professional opinions and visitor attractions.
The campaign which features Greece is particularly timely. In the recent Fertility Tourism Survey 2020 written by Andrew Coutts, Jakub Dejewski and Aleksander Wiecki, it was demonstrated that Greece is fast becoming one of the most popular fertility destinations worldwide. With high quality clinics, staffed by experienced professionals offering excellent levels of care and support it is easy to see why. Add in, accessible travel links, a good climate and a wealth of history and you have the perfect destination.
We look forward to sharing more as the campaign unfolds but for now, take a look at the article below which sets out why Greece was chosen as the first Fertility Destination!
Greece – Fertility destination 2021
Warm Mediterranean climate, tempting blue sea, impressive beaches, amazing historical sites and great food – these are just a few things that Greece is known for. However, not all of us may be aware of the fact that one of the most popular holiday destinations in the world also plays a very important role on the medical tourism map. It turns out that Greece has a lot to offer in terms of in vitro fertilisation and reproductive medicine in general. If you have been considering IVF treatment abroad and were wondering whether Greece was the right choice for you, we say: yes! And here are some reasons why.
You will find many of the world’s top IVF in Greece, combining high-quality services and reasonable rates. These units, mostly located in Athens, Thessaloniki and Crete, apply excellent practices and are staffed with both state-of-the-art technological equipment and trained specialist doctors. The clinics are certified by internationally acclaimed organisations, which assure not only innovation but also safety and quality of clinical, surgical and laboratory procedures.
What is more, all the IVF clinics in Greece operate under license from the Greek National Authority of Assisted Reproduction. It is a national body that makes controls, gives suggestions, collects data and keeps records of every single case related to assisted reproduction in the country. And finally, what is probably most important from a patient’s point of view – first class fertility treatment is offered in Greece at a much lower cost than in other top European fertility destinations.
Greece has definitely a lot of advantages over other countries in terms of infertility treatments and services – one of them is its liberal IVF legislation. Issued in 2005, it allows for most IVF methods (e.g. intracytoplasmic sperm injection (ICSI), egg/sperm donation, frozen embryo transfer), surrogacy arrangements and genetic testing options (such as PGT-A and PGD). The age limit for women undergoing IVF treatment is 50 years old and there are no exceptions in terms of marital status. It means that all the procedures are available to both married and unmarried heterosexual couples, single women and women in lesbian relationships. In case of the latter, it is only required that one partner states she is going through treatment as a single woman and signs a notarial deed.
Greece is one of the countries which allows anonymous egg and sperm donation. According to the Greek IVF law, information on a patient and the child conceived via donation will not be disclosed to an anonymous donor – and vice-versa. Donor anonymity has a lot of advantages: the development of egg/sperm banks, large pools of donor candidates and the lack of waiting lists for donation treatments. The latter will surely be considered as a great asset by advanced-age patients who find time very precious and cannot allow themselves to wait months for the treatment to start.